Danilo Coco1* and Silvana Leanza2
1Department of General Surgery and Surgical Pathology, Ospedali Riuniti Marche Nord, Italy
2Department of General Surgery and Surgical Pathology, Carlo Urbani Hospital Jesi, Italy
Colorectal or bowel cancer is one of the major causes of cancer worldwide. Research has shown that 15% to 20% colorectal cancer patients are also diagnosed with synchronous Liver Metastases (LM) at presentation and about one third eventually develop liver lesions. Management of cases with colorectal cancer comorbid with liver metastases is more complex. This highlights the need for suggesting the need for effective treatment while optimizing timing during surgical and medical treatment of primary plus metastatic disease. Such patients cases are likely to present with severe cancer biology and thereby less likely to be long-term survivors.
Coco D, Leanza S. Analysis of Treatment Option for SynchronousLiver Metastases and Colon RectalCancer. Clin Surg. 2019; 4: 2444.